Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
protease inhibitor intended to treathepatitis C .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word telaprevir.
Examples
-
Vertex owns the North American marketing rights to Incivek, also known as telaprevir, and is seeking marketing approval in other countries through partnerships, including an agreement with Johnson & Johnson.
-
The drug, called telaprevir, would be used in combination with two current therapies.
-
North American marketing rights to Incivek, also known as telaprevir, and is seeking marketing approval in other countries through partnerships, including an agreement with Johnson & Johnson.
USATODAY.com News 2011
-
The results from this trial support the Phase 2 proof-of-concept clinical trial of VX-222 dosed in combination with Vertex's lead investigational HCV protease inhibitor telaprevir, which is expected to complete enrollment in the second quarter of 2010, Vertex said in a press release.
DWS Pill Scribe pillscribe 2010
-
The results from this trial support the Phase 2 proof-of-concept clinical trial of VX-222 dosed in combination with Vertex's lead investigational HCV protease inhibitor telaprevir, which is expected to complete enrollment in the second quarter of 2010.
-
Application submission for telaprevir, which is expected to complete in the fourth quarter of
-
The results from this trial support the Phase 2 proof-of-concept clinical trial of VX-222 dosed in combination with Vertex's lead investigational HCV protease inhibitor telaprevir, which is expected to complete enrollment in the second quarter of 2010.
THE MEDICAL NEWS Editors 2010
-
The results from this trial support the Phase 2 proof-of-concept clinical trial of VX-222 dosed in combination with Vertex's lead investigational HCV protease inhibitor telaprevir, which is expected to complete enrollment in the second quarter of 2010.
THE MEDICAL NEWS Editors 2010
-
U.S. and Canada will speed their reviews of its drug candidate telaprevir, meaning the hepatitis C therapy could be approved months earlier than usual.
Vertex says FDA will rule on telaprevir by May 23 - Yahoo! Finance 2011
-
Vertex said the Food and Drug Administration will do a six-month priority review on telaprevir, meaning the agency expects to make a decision by May 23.
Vertex says FDA will rule on telaprevir by May 23 - Yahoo! Finance 2011
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.